Table 2.

Effect of cisplatin and its combination with bone-marrow derived mesenchymal stem cells (BM-MSCs) on testicular levels of malondialdehyde (MDA), reduced glutathione (GSH), and superoxide dismutase (SOD). All results were expressed as mean ± SD

Group	Normal	Cisplatin	BM-MSCs
MDA nmol/g tissue	36.55 ± 3.15	88.7* ± 6.74	41.58# ± 1.97
GSH mg/g tissue	94.29 ± 3.11	54.55* ± 2.44	84.86# ± 4.6
SOD U/g tissue	70.67 ± 3.4	30.44* ± 2.3	61.1# ± 2.9

^*Significant difference from the normal group at p < 0.05. ^#Significant difference from cisplatin group at p < 0.05